Advertisement
Screener

Codiak BioSciences, Inc. Depreciation and Amortization

Codiak BioSciences, Inc. Depreciation and Amortization

Codiak BioSciences, Inc. reported Depreciation and Amortization of $3.18 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.

Discontinued › Cash Flow › Operating Activities

us-gaap:DepreciationDepletionAndAmortization · last filed 2022-11-03

  • Codiak BioSciences, Inc. depreciation, depletion and amortization for the quarter ending 2022-09-30 was $1.05M, a 24.79% decline year-over-year.
  • Codiak BioSciences, Inc. depreciation, depletion and amortization for the quarter ending 2022-06-30 was $1.05M, a 25.00% decline year-over-year.
  • Codiak BioSciences, Inc. depreciation, depletion and amortization for the quarter ending 2022-03-31 was $1.08M, a 22.22% decline year-over-year.
  • Codiak BioSciences, Inc. depreciation, depletion and amortization for the quarter ending 2021-12-31 was $1.14M, a 11.46% decline year-over-year.
  • Codiak BioSciences, Inc. depreciation, depletion and amortization for fiscal 2021 was $5.34M, a 22.42% increase from fiscal 2020.
  • Codiak BioSciences, Inc. depreciation, depletion and amortization for fiscal 2020 was $4.36M, a 55.82% increase from fiscal 2019.
  • Codiak BioSciences, Inc. depreciation, depletion and amortization for fiscal 2019 was $2.80M.
Period endDepreciation, Depletion and Amortization 3 monthDepreciation, Depletion and Amortization 6 monthDepreciation, Depletion and Amortization 9 monthDepreciation, Depletion and Amortization 9 month as first filedDepreciation, Depletion and Amortization 12 monthDepreciation, Depletion and Amortization 12 month as first filed
2022-09-30$1.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$2.10M
derived: sum of 2 quarters · filed 2022-11-03
$3.18M
10-Q · filed 2022-11-03
$4.32M
derived: sum of 4 quarters · filed 2022-11-03
2022-06-30$1.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$2.13M
10-Q · filed 2022-08-04
$3.26M
derived: sum of 3 quarters · filed 2022-08-04
$4.66M
derived: sum of 4 quarters · filed 2022-08-04
2022-03-31$1.08M
10-Q · filed 2022-05-05
$2.21M
derived: sum of 2 quarters · filed 2022-05-05
$3.61M
derived: sum of 3 quarters · filed 2022-05-05
$5.01M
derived: sum of 4 quarters · filed 2022-05-05
2021-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$2.54M
derived: sum of 2 quarters · filed 2022-03-10
$3.94M
derived: sum of 3 quarters · filed 2022-03-10
$5.34M
10-K · filed 2022-03-10
2021-09-30$1.40M
10-Q · filed 2021-11-04
$2.80M
derived: sum of 2 quarters · filed 2021-11-04
$4.21M
10-Q · filed 2022-11-03
$5.47M
derived: sum of 4 quarters · filed 2022-05-05
2021-06-30$1.40M
10-Q · filed 2021-08-05
$2.76M
10-Q · filed 2022-08-04
$4.07M
derived: sum of 3 quarters · filed 2022-05-05
$5.17M
derived: sum of 4 quarters · filed 2022-05-05
2021-03-31$1.39M
10-Q · filed 2022-05-05
$2.67M
derived: sum of 2 quarters · filed 2022-05-05
$3.77M
derived: sum of 3 quarters · filed 2022-05-05
$4.67M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$2.38M
derived: sum of 2 quarters · filed 2022-03-10
$3.28M
derived: sum of 3 quarters · filed 2022-03-10
$4.36M
10-K · filed 2022-03-10
$4.40M
10-K · filed 2021-03-17
2020-09-30$1.10M
10-Q · filed 2021-11-04
$2.00M
derived: sum of 2 quarters · filed 2021-11-04
$3.08M
10-Q · filed 2021-11-04
$3.10M
10-Q · filed 2020-11-19
$4.03M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$900.00K
10-Q · filed 2021-08-05
$1.97M
10-Q · filed 2021-08-05
$2.93M
derived: sum of 3 quarters · filed 2021-08-05
$3.73M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$1.03M
10-Q · filed 2021-05-06
$2.03M
derived: sum of 2 quarters · filed 2021-05-06
$2.83M
derived: sum of 3 quarters · filed 2021-05-06
2019-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$1.80M
derived: sum of 2 quarters · filed 2021-03-17
$2.80M
10-K · filed 2021-03-17
2019-09-30$800.00K
10-Q · filed 2020-11-19
$1.80M
10-Q · filed 2020-11-19